Suppr超能文献

全国性前瞻性药物利用审查计划对改善老年人潜在不适当药物处方安全性的影响:一项中断时间序列与分段回归分析。

Impact of a nationwide prospective drug utilization review program to improve prescribing safety of potentially inappropriate medications in older adults: An interrupted time series with segmented regression analysis.

机构信息

College of Pharmacy and Gachon Institute of Pharmaceutical Sciences, Gachon University, Incheon, South Korea.

Marcus Institute for Aging Research, Hebrew Senior Life and Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Pharmacoepidemiol Drug Saf. 2021 Jan;30(1):17-27. doi: 10.1002/pds.5140. Epub 2020 Oct 9.

Abstract

PURPOSE

A nationwide prospective drug utilization review (DUR) for potentially inappropriate medications (PIMs) in older adults was implemented in October 2015 in South Korea. We aimed to evaluate the effects of the DUR on reducing PIMs, in comparison with the PIMs defined using the Beers criteria that were not included in the DUR.

METHODS

We divided the study period into a pre- and post-DUR period. The monthly percentage of patients or prescriptions with at least one PIM in the DUR or defined by the Beers criteria was calculated using national health insurance data. We evaluated the effect of the DUR on the prevalence of PIM use in older adults using an interrupted time series with segmented regression analysis.

RESULTS

The prevalence of older adults prescribed PIMs in the DUR decreased by 0.49% (95% confidence interval (CI) [-0.60, -0.37]) based on patient-based measures and, by 0.41% (95% CI [-0.58, -0.23]) based on prescription-based measure, immediately after DUR implementation. However, there were no statistically significant changes in trend. Further, the prevalence of PIMs based on the Beers criteria had no statistically significant changes in terms of either level or trend. After 12 months of DUR, there was a reduction of 11.5% (95% CI [2.6 20.4]) relative to the PIMs in Beers.

CONCLUSIONS

The implementation of a nationwide prospective DUR lowered the prescription of PIMs for older adults. On the other hand, PIMs that were not included were unchanged. Thus, it is worth considering expanding the DUR list to improve prescribing safety.

摘要

目的

2015 年 10 月,韩国在全国范围内开展了一项潜在不适当药物(PIMs)的药物利用审查(DUR)前瞻性研究。我们旨在评估 DUR 对减少 PIMs 的效果,与未纳入 DUR 的 Beers 标准定义的 PIMs 进行比较。

方法

我们将研究期间分为 DUR 前后两个阶段。使用国家健康保险数据,计算 DUR 或 Beers 标准定义的每月至少有一种 PIM 的患者或处方的百分比。我们使用中断时间序列和分段回归分析评估 DUR 对老年人 PIM 使用流行率的影响。

结果

基于患者为基础的措施,DUR 后老年人处方 PIM 的流行率下降了 0.49%(95%置信区间[0.60,-0.37]),基于处方为基础的措施下降了 0.41%(95%置信区间[0.58,-0.23])。然而,趋势没有统计学意义的变化。此外,基于 Beers 标准的 PIMs 的水平和趋势均无统计学意义的变化。在 DUR 实施 12 个月后,与 Beers 中的 PIM 相比,减少了 11.5%(95%置信区间[2.6 20.4])。

结论

实施全国性前瞻性 DUR 降低了老年人的 PIM 处方率。另一方面,未包括的 PIMs 没有变化。因此,值得考虑扩大 DUR 清单以提高处方安全性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验